Journal of Diabetes & Clinical Practice
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • J Diabetes Clin Prac ,

Pharmaceutical innovations and medical knowledge on diabetes for T2DM treatments: A short communication

Chakraborty N
*Corresponding Author :

Chakraborty N



Abstract

Pathogenesis and therapeutics of type 2 diabetes are currently too refractory to be easily managed in the clinics. Medical knowledge and therapeutic options for T2DM treatments are still of great medical significance. We welcome therapeutics of both cutting-edge and traditional for anti-diabetic treatments in future.

Keywords: Glucose, Thyroid, type 2 diabetes mellitus, insulin

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 1584
  • [From(publication date): 0-2020 - Jun 15, 2025]
  • Breakdown by view type
  • HTML page views: 831
  • PDF downloads: 753
Top